v3.25.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Jan. 31, 2023
Operating activities      
Net income (loss) $ (16,596) $ 90,585 $ (182,285)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Depreciation and amortization 187,952 126,838 77,245
Amortization of intangible assets 26,004 18,416 16,565
Amortization of deferred contract acquisition costs 318,837 238,901 170,808
Non-cash operating lease cost 15,283 13,398 9,440
Stock-based compensation expense 865,421 631,519 526,504
Deferred income taxes (9,903) (3,387) 1,306
Realized gains on strategic investments (6,321) (3,936) 0
Accretion of short-term investments purchased at a discount 2,285 (2,285) 0
Non-cash interest expense 3,763 3,173 2,813
Change in fair value of strategic investments 1,000 1,459 (1,830)
Changes in operating assets and liabilities, net of impact of acquisitions      
Accounts receivable, net (274,219) (217,699) (258,109)
Deferred contract acquisition costs (584,484) (371,649) (298,716)
Prepaid expenses and other assets (190,232) (102,520) (46,807)
Accounts payable 84,939 (18,898) (15,463)
Accrued expenses and other liabilities 218,518 14,586 58,923
Accrued payroll and benefits 85,873 65,102 65,226
Operating lease liabilities (15,657) (14,035) (10,364)
Deferred revenue 669,264 696,639 825,751
Net cash provided by operating activities 1,381,727 1,166,207 941,007
Investing activities      
Purchases of property and equipment (254,852) (176,529) (235,019)
Capitalized internal-use software and website development costs (58,969) (49,457) (29,095)
Purchases of strategic investments (19,702) (17,177) (21,808)
Proceeds from sales of strategic investments 12,507 2,000 0
Business acquisitions, net of cash acquired (310,257) (239,030) (18,349)
Purchases of intangible assets 0 (11,126) (2,323)
Purchases of short-term investments 0 (195,581) (250,000)
Proceeds from maturities and sales of short-term investments 97,300 348,281 0
Purchases of deferred compensation investments (2,721) (2,031) (64)
Proceeds from the sale of deferred compensation investments 106 0 0
Net cash used in investing activities (536,588) (340,650) (556,658)
Financing activities      
Repayment of loan payable 0 0 (1,591)
Proceeds from issuance of common stock upon exercise of stock options 3,983 8,695 8,655
Proceeds from issuance of common stock under the employee stock purchase plan 99,616 76,375 59,419
Distributions to non-controlling interest holders (4,891) 0 0
Capital contributions from non-controlling interest holders 8,500 8,088 10,954
Net cash provided by financing activities 107,208 93,158 77,437
Effect of foreign exchange rates on cash, cash equivalents and restricted cash (5,278) 1,958 (1,495)
Net increase in cash, cash equivalents and restricted cash 947,069 920,673 460,291
Cash, cash equivalents and restricted cash at beginning of period 3,377,597 2,456,924 1,996,633
Cash, cash equivalents and restricted cash at end of period 4,324,666 3,377,597 2,456,924
Cash and cash equivalents 4,323,295 3,375,069 2,455,369
Restricted cash included in prepaid expenses and other assets 1,371 2,528 1,555
Total cash, cash equivalents and restricted cash shown in the consolidated statements of cash flows 4,324,666 3,377,597 2,456,924
Supplemental disclosure of cash flow information:      
Interest paid 22,500 22,500 22,551
Income taxes paid, net of refunds received 19,022 22,608 11,943
Supplemental disclosure of non-cash investing and financing activities:      
Net increase (decrease) in property and equipment included in accounts payable and accrued expenses 9,452 (3,081) 22,421
Vesting of early exercised stock options 0 0 2,204
Equity consideration for acquisitions 1,155 652 50
Operating lease liabilities arising from obtaining operating right of-use assets 6,821 16,445 18,464
Proceeds from sales of strategic investments not yet received 4,992 8,774 0
Stock-based compensation included in capitalized software development costs and fixed assets 36,959 31,919 20,193
Noncash consideration for the purchase of strategic investments 3,319 0 0
Noncash consideration received from sales of strategic investments $ 3,319 $ 0 $ 0